Sat.Jun 20, 2020 - Fri.Jun 26, 2020

article thumbnail

Pandemic Gives a Glimpse of Life With a Disability

ComputerTalk

Ordinary life just got more complicated for us all.

75
article thumbnail

Lab Manager Ask the Expert

Drug Patent Watch

Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. [link]. The post Lab Manager Ask the Expert appeared first on DrugPatentWatch - Make Better Decisions.

59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Accelerating your digital IQ for the next normal of customer engagement

pharmaphorum

COVID-19 has brought many changes to the pharmaceutical industry, among them a need to change how pharma companies engage with HCPs and transform their approach to digital channels. This webinar, held in association with Veeva, will present some exclusive market observations from before and during the COVID crisis and explain how pharmaceutical companies can increase their digital IQ and accelerate the move to digital.

article thumbnail

Drug Channels News Roundup, June 2020: CVS’s New GPO, CMS on Copay Accumulators, GoodRx Fees, Supermarket Pharmacies, and Merck’s Ken Frazier

Drug Channels

Happy 244th birthday, America! Before you declare your (socially-distanced) independence, get up close and personal with these Drug Channels fireworks: CVS launches a new GPO for its PBM CMS rethinks copay accumulators Here’s how GoodRx makes money Supermarkets face pharmacy challenges Plus, powerful and important comments from Ken Frazier, CEO of Merck.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Helping The Vocally Impaired Speak in Their Own Voice

ComputerTalk

Thanks to voice banking, digitized speech retains the essence of the original speaker.

40

More Trending

article thumbnail

Episode 516: Can you give lactated ringer’s solution to a patient with elevated lactate?

Pharmacy Joe

In this episode, I’ll discuss giving lactated ringer’s solution to a patient with elevated lactate. Episode 516: Can you give lactated ringer’s solution to a patient with elevated lactate? Subscribe on iTunes , Android , or Stitcher Lactated ringers is considered a suitable fluid for resuscitation in sepsis. In fact, it is becoming more common to use it as a resuscitation fluid as it contains a more physiologic level of chloride than normal saline and is not expected to cause hyperchlorem

article thumbnail

Codeine – It’s Complicated

Med Ed 101

I received a question about codeine and what to expect from its use. When I was first learning pharmacy back in the late 2000s, I saw a lot of codeine. Most frequently, I remember significant use of Tylenol #3. Thankfully, I don’t see it used very often anymore. Why do I say “thankfully”? Codeine kinetics […]. The post Codeine – It’s Complicated appeared first on Med Ed 101.

40
article thumbnail

PMPRB launches consultation on revised Draft Guidelines

Pharma in Brief

On June 19, 2020, the Patented Medicine Prices Review Board ( PMPRB ) launched its consultation on revised Draft Guidelines to implement the amended Patented Medicines Regulations. The revised Guidelines outline new price tests for existing and new patented medicines, as well as a revised risk-based system for reporting and investigations. They will be available for public comment until July 20, 2020.

article thumbnail

Unlocking health data to improve oncology outcomes

pharmaphorum

As use of real-world evidence increases there is an opportunity to improve the patient experience. In addition to key steps forward with the establishment of Health Data Research UK and NHSX, information governance will be key, as is alignment to UK and EU regulations such as the July 2019 DHSC Framework for the Value of NHS Research and GDPR.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Episode 515: IV Push Piperacillin/Tazobactam

Pharmacy Joe

In this episode, I’ll discuss an article about IV push piperacillin-tazobactam. Episode 515: IV Push Piperacillin/Tazobactam Subscribe on iTunes , Android , or Stitcher Article Safety and tolerability of i.v. push piperacillin/tazobactam within an emergency department Lead author: William Blake Hays Published in American Journal of Health-System Pharmacy May 2020 Background Piperacillin/tazobactam is typically administered via IV piggyback over 30 minutes or more increasingly common via extended

article thumbnail

Can I Take Sulfonylureas With a Sulfa Allergy

Med Ed 101

Many patients are labeled as having a “sulfa allergy”. This is typically going to be from a reaction to sulfa antibiotics (i.e. sulfamethoxazole). Sulfonylureas are one of the drug classes that have sulfonamides as part of their chemical structure so therefore a theoretical cross-reactivity is possible. An estimated 3 – 6% of the population are […].

article thumbnail

Federal Courts begin to phase out the Suspension Period

Pharma in Brief

On June 11, 2020 the Federal Court ( FC ) and Federal Court of Appeal ( FCA ) published updated notices to gradually phase out the Suspension Period, which had previously been extended to June 15, 2020. Federal Court. The FC’s June 11, 2020 Practice Direction and Order ( Updated Order ), amends its previous Practice Directions, which, subject to the amendments listed, continue to remain in force.